Mosaic Therapeutics

Mosaic’s use of advanced computational methods, while combining mining of large datasets with experimental approaches to identify and develop novel targeted therapies, completely reinvents the traditional approach to target and drug discovery

Mosaic Therapeutics has raised €25M across 1 funding round from 2 investors, most recently a Series A round in Apr 2023. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.